对搜索策略可用性陈述和系统审查共享实践的研究:问,你可能会收到
Christine J Neilson1, Zahra Premji2
1University of Manitoba, Winnipeg, Manitoba, Canada.
Research synthesis methods
|December 15, 2023
概括
许多系统审查 (SRs) 没有提前提供其搜索策略,即使引用PRISMA指南. 对于这些关键搜索策略的电子邮件请求的成功率很低,影响了研究质量.
科学领域:
- 医学研究方法论医学研究方法论.
- 信息科学 信息科学
背景情况:
- 系统性审查 (SRs) 依赖于文献搜索来收集数据.
- 像PRISMA这样的报告准则旨在提高研究透明度和可重复性.
- 搜索策略是SR质量评估的重要组成部分,正如PRISMA和AMSTAR2所指出的那样.
研究的目的:
- 调查在SR中提供搜索策略的实践.
- 评估通过电子邮件请求搜索策略的有效性,如果没有预先提供.
主要方法:
- 识别了引用PRISMA但使用"搜索可用性声明"的SR.
- 描述了这些评论及其使用搜索可用性声明的特点.
- 向作者发送电子邮件请求他们的搜索策略.
主要成果:
- 其中一半以上的SR引用了PRISMA,但只有不到三分之一提供了搜索策略.
- 电子邮件请求得到了46%的作者的回复.
- 只有36%的作者最终获得了搜索策略.
结论:
- 通过电子邮件请求搜索策略是获得搜索策略的不有效方法.
- 缺乏可访问的搜索策略的SR被AMSTAR2认为是低质量的.
- 期刊编辑应强制将搜索策略纳入SR手稿,以提高研究质量.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Archival Research
16.0K
Some researchers gain access to large amounts of data without interacting with a single research participant. Instead, they use existing records to answer various research questions. This type of research approach is known as archival research. Archival research relies on looking at past records or data sets to look for interesting patterns or relationships. For example, a researcher might access the academic records of all individuals who enrolled in college within the past ten years and...
16.0K
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Hazard Ratio
130
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
130
Statistical Software for Data Analysis and Clinical Trials
563
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
563
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266


